🔗 Share this article

While the US continues making sweeping changes to its immunization recommendations, an unexpected name has emerged somewhat surprisingly: Høeg, a US-based physician and public health researcher who rose to prominence by expressing skepticism about coronavirus shots during the global health crisis and has concentrated on possible deaths following Covid vaccination in her recent time at the Food and Drug Administration.

Planned Changes to Pediatric Immunization Schedule

Health officials planned to reveal sweeping revisions to the pediatric vaccination calendar recently, synchronizing the US with the Danish national calendar, according to reports – a significant shift that would place the US at odds with many the world with little proof for improved outcomes. The planned update has been postponed until the next year.

Instead of Vinay Prasad, Høeg is set to speak at the gathering. She was newly appointed acting director of the FDA’s CDER, the fifth person to run the center this year.

Consolidating Power at the FDA

The acting appointment may indicate a tighter collaboration between the pharmaceutical and biologics branches as Dr. Høeg and Dr. Prasad solidify control at the agency – and it suggests a greater focus upon dismantling already-approved immunizations at the FDA.

Høeg has often pushed for discontinuing certain childhood vaccine recommendations in the US in order to be more similar to Denmark's approach, a society with comprehensive healthcare and a number of inhabitants about the size of the state of Wisconsin.

To date statements, she has persisted in emphasizing on immunizations – traditionally the domain of Prasad, director of the FDA’s Center for Biologics Evaluation and Research (CBER) – instead of drug regulation.

Doubts Over Background

Dr. Høeg has no obvious experience in medication creation, oversight or administrative roles, which has been typical for previous directors of the Center for Biologics Evaluation and Research. She has worked at the FDA as a top consultant to the commissioner and the vaccine center since earlier this year.

“It seems she lacks to have the necessary background” for leading the CDER, stated Jonathan Howard. “She has not conducted a scientific study. She has no expertise in running a major agency. She lacks background in industry regulation.”

Previous heads of the center would “be deeply familiar with laws and regulations and the underlying principles of drug development”, commented Dr. Janet Woodcock. “Frankly, she doesn’t have the type of experience that previous people who led the center have had.”

The drug center has an immense portfolio at the FDA, Woodcock pointed out.

“Many people just pays attention on the innovative therapies, but the generic program clears numerous off-brand pharmaceuticals. There’s a biologic copycat branch, non-prescription drug unit and other areas, and all of those must be managed,” she explained. “The thing you overlook, that is precisely what that I always told people is going to bite you.”

Furthermore, a major management aspect to the role, which manages over 5,000 personnel. “It’s a huge leadership role, if you execute it properly,” Woodcock said.

Official Statement and Disputed Initiatives

When asked about concerns about Dr. Høeg's credentials and whether this appointment indicates greater collaboration among agency officials on immunizations, a press secretary responded that the “questions rely on inaccurate presumptions”.

“Her experience is consistent with the responsibilities of her position,” the spokesperson explained, pointing to the months Dr. Høeg spent counseling the agency head on “medication safety and approval science, including computerized risk analysis and immunization monitoring”.

As acting director, Høeg inherits the agency head's controversial expedited review system, a contentious expedited therapy clearance system that allegedly concerned her former heads. “How are these drugs being picked for this voucher program? Who is making the calls?” Dr. Howard questioned. “There is a lot of secrecy happening at the regulatory body right now.”

Overall, he remarked, “the agency appears to be shifting towards less stringent rules of all drugs, except for immunizations.”

Established Track Record on Immunizations

With immunizations, Dr. Høeg has a more documented, if problematic, track record, some experts said. She authored a analysis using non-validated public submissions to assess the rate of heart inflammation following Covid vaccination. She counseled the Florida chief medical officer Dr. Joseph Ladapo, who allegedly have altered data to imply COVID-19 vaccines are more dangerous than they are.

Included in her “wish list” for the new administration featured changing regulations for novel immunizations and ending “optional” vaccines, she stated following the vote on a podcast. At the agency, Dr. Høeg has reportedly floated the idea of barring teenage boys from getting Covid vaccinations.

“She’s an thorough dogmatist who starts off with her conclusions and reverse-engineers to accommodate the science in a very deceptive, untruthful manner,” Dr. Howard stated.

Consolidating Power and a “Push for Payback”

Høeg aligned with fellow dissenters, {like|